Articles tagged with Colorectal Cancer
A large-scale study of 10,000 adults found that virtual colonoscopy identifies more unsuspected cancers outside the colon than within it. The majority of these cancers were detected at an early stage and have positively affected survival.
Studies reveal significant health disparities among Asian Americans, Native Hawaiians, and Pacific Islanders, with culturally appropriate care shown to reduce cancer rates and heart disease. Immigrant women face high risk of death from breast cancer, while obesity and high blood pressure are major concerns for Native Hawaiians.
Two studies found that using the Third Eye Retroscope (TER) during colonoscopy detected 13.2% more polyps than standard colonoscopy alone, including 11% additional adenomas. The TER improved polyp detection rates significantly with experienced endoscopists.
A recent study found that new chemotherapy drugs for metastatic colorectal cancer can increase life expectancy by 6.8 months, but at a cost of $37,100 per patient. The cost-effectiveness of these treatments is disputed, with the study estimating a cost of $99,100 per quality-adjusted life year gained.
A new study found that obesity is associated with a higher risk of developing colorectal tumors lacking microsatellite instability. The study also revealed that the relationship between body mass index and adult weight gain differs for tumors with varying levels of MSI.
Expression of EpCAM and ABCG5 within tumor buds stratify patients with colorectal cancer into prognostic subgroups, particularly those with node-negative disease. These biomarkers may identify patients at high risk of poor outcome, warranting adjuvant therapy.
A study published in World Journal of Gastroenterology found that the mean age of colorectal cancer in China increased across four regions, with East Guangdong having the highest mean age. The anatomic distribution, histological type, and differentiation type also varied significantly between regions.
A study found that individuals who had colonoscopies performed by non-gastroenterologists, such as general surgeons or internists, were at a higher risk of developing subsequent colorectal cancer. In contrast, gastroenterologists were more proficient at colonoscopy and had a reduced incidence of CRC.
Certain patients with inflammatory bowel disease have an increased risk of developing colorectal cancer. The AGA recommends individualized surveillance plans based on each patient's unique situation, taking into account disease duration, primary sclerosing cholangitis, and family history.
Advanced breast cancer diagnosis among black women is 30-90% higher than among white women between 1992 and 2004. The disparity in advanced colorectal cancer also widens over time. Black women are more likely to be diagnosed with aggressive, hormone-receptor-negative breast cancers that are difficult to detect and treat.
A survey found that most patients are interested in obtaining a video recording of their colonoscopy procedure, with younger patients more willing to pay for the service. Awareness of missed lesions during colonoscopy is a significant predictor of interest in having a video recording.
A study published in Radiology found that computed tomographic colonography (CTC), or virtual colonoscopy, is a safe and effective screening tool for older adults. The advanced neoplastic prevalence was 7.6 percent, with no significant difference in accuracy compared to younger patients.
Researchers at George Mason University are conducting a clinical trial to treat late-stage colorectal cancer patients with tailored therapies based on their tumor's protein profile. The trial uses a novel drug target mapping technology and Gleevec, a medicine typically prescribed for leukemia and gastrointestinal tumors.
Two studies by University of Pittsburgh researchers found that surveillance colonoscopy is being overused in low-risk patients and underused in high-risk patients. The studies suggest that colonoscopy use should be aligned with patient risk to improve healthcare spending.
Researchers found that nine cases of colorectal cancer were diagnosed over 7,626 person-years of observation, with most cancers detected at early stages. The study highlights the importance of close follow-up for patients with a history of advanced adenoma.
A new study published in the Journal of the National Cancer Institute found that colonoscopies significantly reduced the prevalence of left-sided advanced colorectal neoplasms by 85% in a community setting. The study, which analyzed data from 3,287 participants, also showed no significant reduction in right-sided advanced neoplasms.
A new study found that MSH6 mutation carriers have a high risk of developing colorectal and endometrial cancers, as well as cancers associated with Lynch syndrome. The estimated cumulative risks to ages 70 and 80 years were 22% and 44% for colorectal cancer in men, and 26% and 44% for women.
Key advances in DNA sequencing technology and gene mutations have identified candidate cancer genes that contribute to colorectal cancer. The study also highlights the importance of understanding biological pathways deregulated in colon cancer, which can form the basis of new therapeutic agents.
A large-scale case-control study found no association between GSTM1 and GSTT1 null genotypes and increased risk of gastric and colorectal cancer in Koreans. Smoking, alcohol consumption, and age did not modify this association.
Men with a history of nonmetastatic colon cancer who engage in moderate to vigorous physical activity have a significantly lower risk of death from colon cancer and any cause. The study found that men who exercised for more than 27 MET hours per week had over 50% lower mortality rates compared to inactive men.
Researchers at Dana-Farber Cancer Institute found that men with colorectal cancer who engage in regular exercise have a 53% higher chance of surviving without the disease. The benefit of exercise was seen across various factors such as age, cancer progression and previous physical activity.
The German ICGC network will analyze 300 tumor samples of two childhood brain tumors, medulloblastoma and pylocytic astrocytoma. Researchers aim to identify cancer-specific changes and develop new treatment approaches with targeted drugs.
Adding cetuximab to neoadjuvant chemotherapy significantly increases tumor response rates, making more patients eligible for potentially curative surgery. The treatment also improves the proportion of tumors deemed resectable, with a notable increase after treatment.
Scientists at the University of Wisconsin-Madison School of Medicine and Public Health have identified a critical link between two signaling pathways that contribute to the development of colorectal tumors. The study reveals how CRD-BP binds to and increases GLI1 messenger RNA, leading to cancer-promoting gene activation.
New research reveals that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and have a lower likelihood of undergoing surgical procedures compared to Caucasians. This disparity can be attributed to unequal access to care, leading to poorer survival rates.
A study comparing optical diagnosis with conventional histopathology found that optical methods accurately identified up to 93% of small colorectal polyps. The method also enabled quicker follow-up colonoscopies and saved patients an estimated £6560 in clinical appointments.
Studies highlight racial disparities in gastrointestinal disease, particularly colon cancer and Barrett's Esophagus, among African Americans, Latinos, and women. These disparities underscore the importance of education, early screenings, and potentially more aggressive screening tactics for these populations.
A study found that unsedated colonoscopy for primary colorectal cancer screening is as effective as sigmoidoscopy in terms of patient acceptance and need for sedation. The procedure eliminates risks associated with sedation, reduces recovery time, and decreases costs.
A new study found that Jewish survivors of World War II have a higher risk of developing cancer, with increased risks observed for breast and colorectal cancer. The study, which analyzed data from over 300,000 Israeli Jews, suggests that early exposure to extreme stressors during childhood may increase cancer susceptibility later in life.
Researchers found that aspirin and folic acid do not affect inflammation markers in patients with colorectal adenomas. However, low-dose aspirin was found to stabilize C-reactive protein levels, which may be affected by high folate intake.
Women with metastatic colorectal cancer tend to live longer than men, with those under 45 years old experiencing the greatest survival advantage. However, this benefit disappears with age, suggesting that hormones may be contributing to better outcomes in younger patients.
A new study found that investing in colorectal cancer screening programs could reduce treatment costs by more than half. The study suggests that the increasing use of expensive cancer drugs will make screening programs more cost-effective, making them a desirable investment for governments and insurance companies.
Researchers have developed two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers, making diagnosis simpler, cost-effective, and more acceptable to patients. The tests use DNA methylation to detect cancerous cells and show high sensitivity and specificity rates.
A new study published in the Journal of the National Cancer Institute found that fecal DNA methylation can detect gastric and colorectal cancers. Methylation patterns were more likely to be found in advanced tumors, with detection rates of 57% for gastric cancer patients and 75% for colorectal cancer patients.
Researchers have discovered genetic biomarkers relevant to CRC, allowing for personalized medication and improved survival rates. The integration of conventional agents with novel targeted therapies has led to median overall survival exceeding two years in metastatic CRC.
Regular postdiagnosis aspirin use may reduce the risk of dying from colorectal cancer, with a nearly 30% lower risk seen in patients taking aspirin at least twice a week. The benefit is strongest among patients with COX-2-positive tumors.
Regular aspirin use after diagnosis was associated with reduced risks of colorectal cancer-specific death and overall mortality. Participants who regularly used aspirin had a 29% lower risk of colorectal-specific mortality compared to nonusers.
A study found that cetuximab was not cost-effective for all patients with advanced colorectal cancer. However, it showed promise when used in patients whose tumors had wild-type KRAS genes. The authors suggest restricting cetuximab treatment to these patients to save costs.
The new UIC Center of Excellence in Eliminating Health Disparities aims to reduce health disparities in Chicago by conducting research, education, policy changes, and community partnerships. Researchers will focus on prostate and colorectal cancer, as well as breast cancer initiatives.
Researchers at Children's Hospital of Philadelphia have identified an immune mechanism responsible for graft failure in a mouse model of IUHCT. Maternal alloantibodies, produced in response to IUHCT, trigger a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation. This finding opens the...
Researchers have discovered a key link between protein CCKR2 and progastrin-related colonic hyperproliferation. Deletion of the Cck2r gene in mice with human progastrin overexpression abolished colonic hyperproliferation and reduced colorectal cancer, suggesting CCKR2 as a viable target for treatment.
A new study found that most older long-term cancer survivors with an interest in diet and exercise actually have poor health habits. However, those who exercised regularly and followed a healthy diet experienced improved physical health and quality of life.
A study found that increasing lymph node removal did not increase the number of patients with stage III colorectal cancer. Despite higher lymph node yields, the proportion of patients diagnosed with stage III cancer remained unchanged.
A decision-analytic model suggests that more frequent and strict colonoscopy recommendations can be cost-effective strategies for screening second primary colorectal cancers in male cancer survivors. The most vulnerable population aged 40 years old may benefit from COL5, while the general population aged 50 years old may follow COL10.
Researchers found that ultrasound outperforms symptom analysis in detecting ovarian cancer, with TVS performing better for malignancies. Racial disparities in colorectal cancer survival dissipate after adjusting for demographic and clinical factors. Thyroid cancer incidence increases across all tumor sizes, suggesting screening is not ...
Researchers at Max Delbrück Center for Molecular Medicine have identified 115 genes associated with metastatic potential in colorectal cancer. The study found that BAMBI gene is more active in metastatic tumors, promoting metastasis formation through key signaling pathways.
A University at Buffalo study found that improved communication between patients and primary care physicians increases the chances of those due for screening following their doctor's advice. The more convenient the screening process is, the greater the chance patients will follow through.
Researchers identified a novel mechanism linking a common single-base variant in chromosome 8 to an increased risk of colorectal cancer. This variant is carried by nearly all African populations and contributes significantly to the disease at a population level, yet its impact on individual susceptibility is minimal.
Researchers found increased mRNA levels of PN-1, a prostasin inhibitor, in colorectal tissue samples from patients with mild/moderate dysplasia and severe dysplasia before colorectal cancer. Elevated PN-1 levels coincide with the acquisition of malignant properties in colorectal tissue.
A recent study found that colorectal cancer incidence rates decreased significantly among whites aged 65 and over, but not among those in poorer communities. The researchers suggest that lack of access to healthcare may be the reason for this disparity. Colorectal endoscopic screening rates also increased among whites, but were lower a...
Researchers have identified N-Myc downstream-regulated gene 4 (NDRG4) as a potential biomarker for colorectal cancer and a candidate tumor suppressor gene. The study found that NDRG4 promoter methylation was more prevalent in colorectal cancers than in noncancerous colon mucosa.
A new CT scan method has been shown to be accurate in detecting colorectal cancer in individuals at increased risk. The study found a sensitivity of 85.3% and specificity of 87.8%, making it a potentially effective alternative to colonoscopy for screening.
A recent study found that US counties with a higher percentage of African-American patients tend to have fewer gastroenterologists and radiation oncologists, while those with more Asian Americans have more specialists. This disparity is linked to disparities in access to quality healthcare services.
A study published in World Journal of Gastroenterology found that patients with extrahepatic disease, high carcinoembriogenic antigen levels, or multiple nodules have poorer survival rates. Despite this, advances in surgical technique and complementary treatments are increasing the number of patients benefiting from curative treatment.
A study published in the World Journal of Gastroenterology found that current alcohol drinking and a high body mass index (BMI) ≥ 24.0 kg/m2 are independent risk factors for colon and rectal cancer. Former alcohol consumption and a positive family history of cancer are also linked to an increased risk of colon cancer.
Researchers develop synthetic protein that induces blood clotting, cutting off tumor's nutrient and oxygen supply. The treatment resulted in a 53% decrease in tumor volume and slowed cancer cell growth by 49%.
Australian researchers have developed gene expression biomarkers that can accurately detect pre-cancerous and cancerous colorectal growths from non-cancerous controls. This breakthrough is a result of a collaborative study involving CSIRO, Flinders University, and Clinical Genomics Pty Ltd.
A global study found colorectal cancer incidence rates for males and females increased in 27 countries between 1983 and 2002. The rise is attributed to Westernization and lifestyle changes, including obesity, physical inactivity, and diet.
Incidence rates of colorectal cancer are rising among young adults in the US due to increased obesity and unfavorable dietary patterns. Studies found a 1.5% annual increase in incidence rates from 1992-2005, with left-sided tumors being more common.
A new DNA stool test has been developed by Mayo Clinic researchers to detect digestive cancers in multiple organs, including pancreas, stomach, and esophageal cancers. The test was shown to be highly sensitive, detecting cancers at each organ site with high accuracy.